GeneDx Holdings Common Stock Net 2020-2025 | WGS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GeneDx Holdings common stock net from 2020 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GeneDx Holdings common stock net from 2020 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$148.1B
CVS Health (CVS)	$75.9B
Elevance Health (ELV)	$65B
Cencora (COR)	$56.2B
DiDi Global (DIDIY)	$25.7B
Labcorp Holdings (LH)	$21.9B
Natera (NTRA)	$18.5B
BioMerieux (BMXMF)	$17.1B
EUROFINS SCIENT (ERFSF)	$15.2B
ICON (ICLR)	$15B
CochLear (CHEOY)	$13.6B
Solventum (SOLV)	$12.7B
Medpace Holdings (MEDP)	$12.6B
Revvity (RVTY)	$11.1B
Viatris (VTRS)	$10.8B
Avantor (AVTR)	$9.5B
Sonic Healthcare (SKHHY)	$9.1B
Charles River Laboratories (CRL)	$8.8B
HealthEquity (HQY)	$8.3B
Caris Life Sciences,�Inc (CAI)	$7B
Bausch + Lomb (BLCO)	$5.2B
Amplifon S.p.A (AMFPF)	$5.1B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.4B
Surgery Partners (SGRY)	$2.9B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.6B
Alignment Healthcare (ALHC)	$2.3B
Progyny (PGNY)	$2B
PACS (PACS)	$1.8B